riluzole has been researched along with Dyskinesia, Drug-Induced in 7 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Pagliaroli, L | 2 |
| Fothi, A | 1 |
| Nespoli, E | 2 |
| Liko, I | 1 |
| Veto, B | 1 |
| Devay, P | 1 |
| Szeri, F | 1 |
| Hengerer, B | 2 |
| Barta, C | 2 |
| Aranyi, T | 1 |
| Widomska, J | 1 |
| Hildebrandt, T | 1 |
| Glennon, J | 1 |
| Poelmans, G | 1 |
| Lundblad, M | 1 |
| Usiello, A | 1 |
| Carta, M | 1 |
| Håkansson, K | 1 |
| Fisone, G | 1 |
| Cenci, MA | 1 |
| Bara-Jimenez, W | 1 |
| Dimitrova, TD | 1 |
| Sherzai, A | 1 |
| Aksu, M | 1 |
| Chase, TN | 1 |
| Merims, D | 2 |
| Ziv, I | 2 |
| Djaldetti, R | 2 |
| Melamed, E | 2 |
| Vale, S | 1 |
| Sherki, Y | 1 |
1 trial available for riluzole and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Glutamate release inhibition ineffective in levodopa-induced motor complications.
Topics: Aged; Antiparkinson Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administrati | 2006 |
6 other studies available for riluzole and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Riluzole Administration to Rats with Levodopa-Induced Dyskinesia Leads to Loss of DNA Methylation in Neuronal Genes.
Topics: Animals; Corpus Striatum; DNA Methylation; Dyskinesia, Drug-Induced; Levodopa; Rats; Rats, Wistar; R | 2021 |
Riluzole Attenuates L-DOPA-Induced Abnormal Involuntary Movements Through Decreasing CREB1 Activity: Insights from a Rat Model.
Topics: Animals; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Dyskinesia, Drug-Induc | 2019 |
Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.
Topics: Adenosine A2 Receptor Agonists; Adrenergic Agents; Amantadine; Animals; Antiparkinson Agents; Basal | 2005 |
Riluzole for levodopa-induced dyskinesias in advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; N | 1999 |
Drug treatments of levodopa-induced dyskinesias.
Topics: Amantadine; Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Excitatory Amino Acid A | 1999 |
The role of glutamatergic transmission in the pathogenesis of levodopa-induced dyskinesias. Potential therapeutic approaches.
Topics: Anticonvulsants; Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Excitatory Amino A | 2001 |